Medidata NEXT Seoul & Shanghai Events Host Industry Thought Leaders at the Forefront of the Digital Transformation in Life Sc...
July 11 2018 - 05:58PM
Business Wire
China Drug Administration and Celltrion Lead
Keynote Sessions
This week, the Asia Pacific segment of Medidata’s (NASDAQ:MDSO)
global NEXT series continues with customer events in Seoul and
Shanghai. Sessions will explore trends in virtual trials, mobile
healthcare, real-world evidence, artificial intelligence, and
machine learning.
The digital transformation of clinical trials is among the many
topics being discussed by company executives and hundreds of life
science leaders in the region.
NEXT Seoul concluded Tuesday with more than 400
attendees. Keynote speakers included Professor Daeho Lee from Asan
Medical Center who discussed the importance of patient centricity
in clinical research, and Mr. Sangjoon Lee who outlined how
technology revolutionized new drug development for his company,
Celltrion.
NEXT Shanghai takes place Thursday, with over 800
attendees expected from leading pharmaceutical companies, including
Fosun, and 13 CRO sponsors, including Paraxel, TigerMed, FMD
K&L, and Wuxi CDS. Keynote speakers from China Drug
Administration (formerly CFDA) and University of Tokyo Hospital in
Shanghai will explore the future blueprint of drug development.
“This week is a great opportunity for life science leaders in
the region to share insight about the future of drug development,”
said Glen de Vries, president and co-founder, Medidata. “I’m
excited to join over 1,200 customers and partners as we discuss the
digital transformation of our industry.”
Learn more about Medidata NEXT global events and register today
for NEXT NYC.
About Medidata
Medidata is leading the digital transformation of life sciences,
with the world's most used platform for clinical development,
commercial, and real-world data. Powered by artificial intelligence
and delivered by the #1 ranked industry experts, the Intelligent
Platform for Life Sciences helps pharmaceutical, biotech, medical
device companies, and academic researchers accelerate value,
minimize risk and optimize outcomes. Medidata serves more than
1,000 customers and partners worldwide and empowers more than
100,000 certified users everyday to create hope for millions of
patients. Discover the future of life sciences: www.mdsol.com
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180711005864/en/
Medidata SolutionsInvestors:Betsy Frank,
917-522-4620bfrank@mdsol.comorMedia:Erik Snider,
646-362-2997esnider@mdsol.com
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Feb 2024 to Mar 2024
Medidata Solutions (NASDAQ:MDSO)
Historical Stock Chart
From Mar 2023 to Mar 2024